Cingulate Inc. (CING) stock
CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
$4.64+0.08 (+1.75%)
Close on Nov 11, 2026Market cap $67.47MP/E –Yield –
Cingulate cash
Cash and short-term investments held at the end of each period.
Cingulate's cash was $28.40M at Jun 30, 2026. For fiscal 2025 it was $10.95M, down 10.3% from the year before. The highest annual figure on record is $16.49M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.95M | -10.3% |
| FY2024 | Dec 31, 2024 | $12.21M | +23196.9% |
| FY2023 | Dec 31, 2023 | $52.42K | -99.0% |
| FY2022 | Dec 31, 2022 | $5.36M | -67.5% |
| FY2021 | Dec 31, 2021 | $16.49M | +1276.1% |
| FY2020 | Dec 31, 2020 | $1.20M | +186.4% |
| FY2019 | Dec 31, 2019 | $418.47K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.40M | +219.1% |
| Q1 FY2026 | Mar 31, 2026 | $25.89M | +172.0% |
| Q4 FY2025 | Dec 31, 2025 | $10.95M | -10.3% |
| Q3 FY2025 | Sep 30, 2025 | $6.12M | -39.1% |
| Q2 FY2025 | Jun 30, 2025 | $8.90M | +699.1% |
| Q1 FY2025 | Mar 31, 2025 | $9.52M | +18060.4% |
| Q4 FY2024 | Dec 31, 2024 | $12.21M | +514.8% |
| Q3 FY2024 | Sep 30, 2024 | $10.04M | +2770.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.11M | -35.9% |
| Q4 FY2023 | Dec 31, 2023 | $52.42K | -99.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.99M | -79.7% |
| Q2 FY2023 | Jun 30, 2023 | $349.83K | -95.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.74M | -86.2% |
| Q4 FY2022 | Dec 31, 2022 | $5.36M | -67.5% |
| Q3 FY2022 | Sep 30, 2022 | $9.80M | +717.2% |
| Q2 FY2022 | Jun 30, 2022 | $8.20M | +1858.5% |
| Q1 FY2022 | Mar 31, 2022 | $12.62M | – |
| Q4 FY2021 | Dec 31, 2021 | $16.49M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.20M | – |
| Q4 FY2019 | Dec 31, 2019 | $418.47K | – |
See a number that looks wrong?